In Vivo Susceptibility of Plasmodium Vivax to Chloroquine in Southeastern Iran

In Vivo Susceptibility of Plasmodium Vivax to Chloroquine in Southeastern Iran

Show other versions (1)

Background: Plasmodium vivax is the predominant species causes of malaria with about 90% total annual reported malaria in Iran. This study conducted to determine the susceptibility of Plasmodium vivax isolates to chloroquine in Sistan and Balochistan Province, southeastern Iran.Methods: A total 270...

Full description

Bibliographic Details
Main Authors:	S Dittrich, A Raeisi, S Shojaee, H Keshavarz, A Heidari
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2012-06-01
Series:	Iranian Journal of Parasitology
Subjects:	Malaria Plasmodium Vivax Chloroquine Iran
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/20952.pdf&manuscript_id=20952

Similar Items

In vivo Susceptibility of Plasmodium vivax to Chloroquine in Southeastern Iran
by: A Heidari, et al.
Published: (2012-06-01)

PLASMODIUM VIVAX MALARIA: CLINICAL COURSE AND FREQUENCY OF RESISTANCE AGAINST CHLOROQUINE
by: Muhammad Asif Nizami, et al.
Published: (2021-02-01)

Molecular epidemiology of potential candidate markers for chloroquine resistance in imported Plasmodium vivax malaria cases in Iran
by: Sakineh Pirahmadi, et al.
Published: (2023-04-01)

Monitoring of Plasmodium vivax and Plasmodium falciparum response to chloroquine in Bandar-Abbas district, Hormozgan province, Iran
by: Nateghpour M M, et al.
Published: (2009-06-01)

Chloroquine-Resistant Plasmodium vivax, Brazilian Amazon
by: Franklin Simoes de Santana Filho, et al.
Published: (2007-07-01)

Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon
by: André M Siqueira, et al.
Published: (2014-08-01)

Assessment of Therapeutic Response of Plasmodium vivax and Plasmodium falciparum to Chloroquine in a Malaria Transmission Free Area in Colombia
by: Castillo Carmen Manuela, et al.
Published: (2002-01-01)

Chloroquine resistant vivax malaria in an infant: a report from India
by: Ira Shah
Published: (2008-05-01)

Genetic diversity of chloroquine-resistant Plasmodium vivax parasites from the western Brazilian Amazon
by: Omaira Vera Lizcano, et al.
Published: (2014-11-01)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01)

Emerging Plasmodium vivax resistance to chloroquine in South America: an overview
by: Lígia Antunes Gonçalves, et al.
Published: (2014-08-01)

In vivo Susceptibility of Plasmodium vivax to Chloroquine in Southeastern Iran.
by: Heidari, A, et al.
Published: (2012)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
by: Jutta Marfurt, et al.
Published: (2021-12-01)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
by: André Daher, et al.
Published: (2022-01-01)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
by: Chamnanphon M, et al.
Published: (2020-01-01)

Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial
by: André Daher, et al.
Published: (2018-01-01)

Respuesta terapéutica de Plasmodium vivax a la cloroquina, en Riberalta, Guayaramerín y Yacuiba, Bolivia
by: Arletta Añez, et al.
Published: (2012-12-01)

Severe Plasmodium vivax Malaria, Brazilian Amazon
by: Márcia A. Alexandre, et al.
Published: (2010-10-01)

Therapeutic efficacy of artemether-lumefantrine for <it>Plasmodium vivax</it> infections in a prospective study in Guyana
by: Eibach Daniel, et al.
Published: (2012-10-01)

Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial
by: Grigg, Matthew J., et al.
Published: (2016)

Fatal Case of Plasmodium vivax Malaria in a Splenectomized Patient
by: H Mahmoudvand, et al.
Published: (2012-09-01)

Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam
by: Nguyen Chinh Phong, et al.
Published: (2019-01-01)

Diez años de eficacia terapéutica de la cloroquina en malaria no complicada por Plasmodium vivax, Turbo, Antioquia, años 2002 y 2011
by: Alexandra Ríos, et al.
Published: (2013-09-01)

In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009–2010
by: Kanungnit Congpuong , Wichai Satimai , Anupong Sujariyakul , Somchai Intanakom, Warunee Harnpitakpong , Yuttana Pranuth , Sawad Cholpol & Pongwit Bualombai
Published: (2011-12-01)

Plasmodium Vivax Associated Myocarditis
by: Ajinkya A Sonambekar, et al.
Published: (2014-04-01)

Genetic diversity of merozoite surface protein-5 (MSP-5) of Plasmodium vivax isolates from Malaria patients in Iran
by: Sholeh Mansouri, et al.
Published: (2023-11-01)

Malaria congénita en un hospital de iquitos, Perú
by: Hermann Silva, et al.

The Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran
by: Mohammad Ebrahimipour, et al.
Published: (2014-09-01)

Genetic Variation of MSP-1 Gene in Plasmodium vivax Isolated from Patients in Hormozgan Province, Iran using SSCP-PCR
by: M Rezaeian, et al.
Published: (2012-12-01)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
by: André Daher, et al.
Published: (2019-09-01)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
by: Cecilia Giraldo, et al.
Published: (1991-01-01)

Genetic Variation and Selection of Domain I of the Plasmodium vivax Apical Membrane Antigen-1(AMA-1) Gene in Clinical Isolates from Iran
by: Aliehsan Heidari, et al.
Published: (2013-12-01)

Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms
by: Hongyun Ding, et al.
Published: (2023-11-01)

Thrombocytopenia and its Comparison with Plasmodium Vivax and Plasmodium Falciparum in Malaria Patients
by: Maliha Ajmal, et al.
Published: (2023-01-01)

Detection of Asymptomatic Carriers of Plasmodium vivax among Treated Patients by Nested PCR Method in Minab, Rudan and Bashagard, Iran
by: Abbas Shahbazi, et al.
Published: (2013-12-01)

Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros
by: Randrianarivelojosia M., et al.
Published: (2004-12-01)

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Robert J. Commons, et al.
Published: (2019-08-01)

Genetic Diversity in C-terminal of SERA5 Gene in the Blood Stage of Human Isolates of Plasmodium vivax in Sistan and Baluchistan, Iran
by: Ahmad ABOLGHAZI, et al.
Published: (2018-09-01)

The clinicopathologic manifestations of plasmodium vivax malaria in children
by: Hareesh Resu, et al.
Published: (2019-01-01)

An unlabelled probe-based real time PCR and modified semi-nested PCR as molecular tools for analysis of chloroquine resistant Plasmodium vivax isolates from Afghanistan
by: Sayed Hussain Mosawi, et al.
Published: (2020-07-01)